Presentations

Cinclus Pharma participates at Swiss Nordic Bio 2025

Cinclus News Image Swiss Nordic Bio 01

to

Webcast

Read more and register

Cinclus Pharma participates at Swiss Nordic Bio March 13

CEO Christer Ahlberg will present the company and the development of the drug candidate linaprazan glurate.

Speakers

cinclus pharma ceo christer ahlberg

Christer Ahlberg

CEO